Musculoskeletal Research Unit, School of Clinical Sciences, University of Bristol, Bristol, UK.
Lancet. 2013 Sep 28;382(9898):1097-104. doi: 10.1016/S0140-6736(13)61749-3.
Death within 90 days after total hip replacement is rare but might be avoidable dependent on patient and treatment factors. We assessed whether a secular decrease in death caused by hip replacement has occurred in England and Wales and whether modifiable perioperative factors exist that could reduce deaths.
We took data about hip replacements done in England and Wales between April, 2003, and December, 2011, from the National Joint Registry for England and Wales. Patient identifiers were used to link these data to the national mortality database and the Hospital Episode Statistics database to obtain details of death, sociodemographics, and comorbidity. We assessed mortality within 90 days of operation by Kaplan-Meier analysis and assessed the role of patient and treatment factors by Cox proportional hazards model.
409,096 primary hip replacements were done to treat osteoarthritis. 1743 patients died within 90 days of surgery during 8 years, with a substantial secular decrease in mortality, from 0·56% in 2003 to 0·29% in 2011, even after adjustment for age, sex, and comorbidity. Several modifiable clinical factors were associated with decreased mortality according to an adjusted model: posterior surgical approach (hazard ratio [HR] 0·82, 95% CI 0·73-0·92; p=0·001), mechanical thromboprophylaxis (0·85, 0·74-0·99; p=0·036), chemical thromboprophylaxis with heparin with or without aspirin (0·79, 0·66-0·93; p=0·005), and spinal versus general anaesthetic (0·85, 0·74-0·97; p=0·019). Type of prosthesis was unrelated to mortality. Being overweight was associated with lower mortality (0·76, 0·62-0·92; p=0·006).
Postoperative mortality after hip joint replacement has fallen substantially. Widespread adoption of four simple clinical management strategies (posterior surgical approach, mechanical and chemical prophylaxis, and spinal anaesthesia) could, if causally related, reduce mortality further.
National Joint Registry for England and Wales.
全髋关节置换术后 90 天内死亡较为罕见,但可能取决于患者和治疗因素。我们评估了在英格兰和威尔士,髋关节置换术后导致的死亡率是否呈下降趋势,以及是否存在可改变的围手术期因素来降低死亡率。
我们从英格兰和威尔士国家关节登记处获取了 2003 年 4 月至 2011 年 12 月期间在英格兰和威尔士进行的髋关节置换术的数据。使用患者标识符将这些数据与国家死亡率数据库和医院入院统计数据库相关联,以获取手术死亡、社会人口统计学和合并症的详细信息。我们通过 Kaplan-Meier 分析评估术后 90 天内的死亡率,并通过 Cox 比例风险模型评估患者和治疗因素的作用。
共进行了 409096 例原发性髋关节置换术治疗骨关节炎。在 8 年期间,有 1743 名患者在术后 90 天内死亡,死亡率呈显著下降趋势,从 2003 年的 0.56%下降到 2011 年的 0.29%,即使在调整了年龄、性别和合并症后也是如此。根据调整后的模型,一些可改变的临床因素与死亡率降低有关:后入路手术(风险比 [HR]0.82,95%CI0.73-0.92;p=0.001)、机械血栓预防(0.85,0.74-0.99;p=0.036)、肝素联合或不联合阿司匹林的化学血栓预防(0.79,0.66-0.93;p=0.005)和椎管内麻醉与全身麻醉(0.85,0.74-0.97;p=0.019)。假体类型与死亡率无关。超重与较低的死亡率相关(0.76,0.62-0.92;p=0.006)。
髋关节置换术后的术后死亡率已大幅下降。如果这些与因果相关,广泛采用四项简单的临床管理策略(后路手术、机械和化学预防以及椎管内麻醉)可能会进一步降低死亡率。
英格兰和威尔士国家关节登记处。